Influenza - Insights from mathematical modelling;Influenza - Einsichten aus mathematischer modellierung

Deutsches Arzteblatt

Volumn 106, Issue 47, 2009, Pages 777-782

  Mikolajczyk, Rafael ^a   Krumkamp, Ralf ^b   Bornemann, Reinhard ^c   Ahmad, Amena ^b   Schwehm, Markus ^d   Duerr, Hans Peter ^e  

^a BIELEFELD UNIVERSITY   (Germany)

^b HAMBURG UNIVERSITY OF APPLIED SCIENCES   (Germany)

^c BIELEFELD UNIVERSITY OF APPLIED SCIENCES   (Germany)

^d EXPLOSYS GMBH   (Germany)

^e UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Defense against infection; Disease course; Epidemic; Influenza; Prevention

Indexed keywords

CONTACT EXAMINATION; DISEASE COURSE; DISEASE TRANSMISSION; EPIDEMIC; HUMAN; INCUBATION TIME; INFECTION CONTROL; INFLUENZA; INFLUENZA VACCINATION; LATENT PERIOD; MATHEMATICAL MODEL; PROPHYLAXIS; REVIEW; VALIDATION STUDY;

COMPUTER SIMULATION; DISEASE OUTBREAKS; GERMANY; HUMANS; INCIDENCE; INFLUENZA, HUMAN; MODELS, BIOLOGICAL; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS;

EID: 76149134337     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2009.0777     Document Type: Review

References (30)

1. Bornemann R: Evidenzbasierte Public Health bei Influenzapandemieplanung. In: Breckenkamp J, Gerhardus A, Razum O, Schmacke N, Wenzel H (eds.): Evidence-Based Public Health, Reihe Handbuch Gesundheitswissenschaften. Bern: Hans Huber 2009.
2. Lipsitch M, Riley S, Cauchemez S, Ghani AC, Ferguson NM: Managing and reducing uncertainty in an emerging influenza pandemic. N Engl J Med 2009; 361: 112-5.
3. Fraser C, Riley S, Anderson RM, Ferguson NM: Factors that make an infectious disease outbreak controllable. Proc Natl Acad Sci USA 2004; 101: 6146-51.
4. Bettencourt LM, Ribeiro RM: Real time bayesian estimation of the epidemic potential of emerging infectious diseases. PLoS One 2008; 3: e2185.
5. Jewell CP, Kypraios T, Christley RM, Roberts GO: A novel approach to real-time risk prediction for emerging infectious diseases: a case study in Avian Influenza H5N1. Prev Vet Med 2009; 91: 19-28.
6. Carrat F, Vergu E, Ferguson NM, et al.: Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008; 167: 775-85.
7. Nishiura H, Castillo-Chavez C, Safan M, Chowell G: Transmission potential of the new influenza A(H1N1) virus and its age-specificity in Japan. Euro Surveill 2009; 14: 19227.
8. Boelle PY, Bernillon P, Desenclos JC: A preliminary estimation of the reproduction ratio for new influenza A(H1N1) from the outbreak in Mexico, March-April 2009. Euro Surveill 2009; 14: 19205.
9. Fraser C, Donnelly CA, Cauchemez S, et al.: Pandemic potential of a strain of influenza A (H1N1): early findings. Science 2009; 324: 1557-61.
10. an der Heiden M: Möglicher Verlauf einer Epidemie durch das Neue Influenzavirus A/H1N1 in Deutschland und Auswirkungen präventiver Maßnahmen des Öffentlichen Gesundheitsdienstes. Epidemiol Bulletin 2009; 22: 221-6.
11. Eichner M, Schwehm M, Duerr HP, Brockmann SO: The influenza pandemic preparedness planning tool InfluSim. BMC Infect Dis 2007; 7: 17.
12. Vidondo B, Oberreich J, Brockmann SO, Duerr HP, Schwehm M, Eichner M: Effects of interventions on the demand for hospital services in an influenza pandemic: a sensitivity analysis. Swiss Med Wkly 2009; 139: 505-10.
13. Eichner M, Schwehm M, Duerr HP, et al.: Antiviral prophylaxis during pandemic influenza may increase drug resistance. BMC Infect Dis 2009; 9: 4.
14. Brockmann SO, Schwehm M, Duerr HP, et al.: Modelling the effects of drug resistant influenza virus in a pandemic. Virol J 2008; 5: 133.
15. Cooper BS, Pitman RJ, Edmunds WJ, Gay NJ: Delaying the international spread of pandemic influenza. PLoS Med 2006; 3: e212.
16. Pitman RJ, Cooper BS, Trotter CL, Gay NJ, Edmunds WJ: Entry screening for severe acute respiratory syndrome (SARS) or influenza: policy evaluation. BMJ 2005; 331: 1242-3.
17. Bell DM: Non-pharmaceutical interventions for pandemic influenza, national and community measures. Emerg Infect Dis 2006; 12: 88-94.
18. Nishiura H, Wilson N, Baker MG: Quarantine for pandemic influenza control at the borders of small island nations. BMC Infect Dis 2009; 9: 27.
19. Klinkenberg D, Fraser C, Heesterbeek H: The effectiveness of contact tracing in emerging epidemics. PLoS ONE 2006; 1: e12.
20. Wallinga J, Teunis P, Kretzschmar M: Using data on social contacts to estimate age-specific transmission parameters for respiratoryspread infectious agents. Am J Epidemiol 2006; 164: 936-44.
21. Mossong J, Hens N, Jit M, et al.: Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 2008; 5: e74.
22. Mikolajczyk RT, Akmatov MK, Rastin S, Kretzschmar M: Social contacts of school children and the transmission of respiratory-spread pathogens. Epidemiol Infect 2008; 136: 813-22.
23. Kretzschmar M, Mikolajczyk RT: Contact profiles in eight European countries and implications for modelling the spread of airborne infectious diseases. PLoS One 2009; 4: e5931.
24. Germann TC, Kadau K, Longini IM Jr., Macken CA: Mitigation strategies for pandemic influenza in the United States. Proc Natl Acad Sci USA 2006; 103: 5935-40
25. Ferguson NM, Cummings DA, Fraser C, Cajka JC, Cooley PC, Burke DS: Strategies for mitigating an influenza pandemic. Nature 2006; 442: 448-52.
26. Cauchemez S, Valleron AJ, Boelle PY, Flahault A, Ferguson NM: Estimating the impact of school closure on influenza transmission from sentinel data. Nature 2008; 452: 750-4.
27. Heymann AD, Hoch I, Valinsky L, Kokia E, Steinberg DM: School closure may be effective in reducing transmission of respiratory viruses in the community. Epidemiol Infect 2009; 137: 1-8.
28. Longini IM Jr., Halloran ME, Nizam A, Yang Y: Containing pandem ic influenza with antiviral agents. Am J Epidemiol 2004; 159: 623-33.
29. Gani R, Hughes H, Fleming D, Griffin T, Medlock J, Leach S: Potential impact of antiviral drug use during influenza pandemic. Emerg Infect Dis 2005; 11: 1355-62.
30. Lipsitch M, Cohen T, Murray M, Levin BR: Antiviral resistance and the control of pandemic influenza. PLoS Med 2007; 4: e15.